Non-Hodgkin's lymphoma

Rappaport, 1966 Jaffe, 1990, The role of immunophenotypic markers in the classification of non-Hodgkin's lymphomas, Semin Oncol, 17, 11 Wingo, 1995, Cancer Statistics, 1995, CA Cancer J Clin, 45, 8, 10.3322/canjclin.45.1.8 Cantor, 1980, Distribution of non-Hodgkin's lymphoma in the United States between 1950 and 1975, Cancer Res, 40, 2645 Palackdharry, 1994, Non-Hodgkin's lymphoma: why the rising incidence?, Oncology, 8, 67 Zahm, 1992, Pesticides and non-Hodgkin's lymphoma, Cancer Res, 52, 5485S Scherr, 1992, Non-Hodgkin's lymphoma and occupational exposure, Cancer Res, 52, 5503S Lipkowitz, 1992, Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies, 89, 5301 Grierson, 1987, Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome, Ann Intern Med, 106, 538, 10.7326/0003-4819-106-4-538 Filipovich, 1987, The immunodeficiency cancer registry, Am J Pediatr Hematol Oncol, 9, 183, 10.1097/00043426-198722000-00017 Kassan, 1978, Increased risk of lymphoma in sicca syndrome, Ann Intern Med, 89, 888, 10.7326/0003-4819-89-6-888 Ahmed, 1987, Malignant lymphoma in a population at risk for acquired immunodeficiency syndrome, Cancer, 60, 719, 10.1002/1097-0142(19870815)60:4<719::AID-CNCR2820600402>3.0.CO;2-U Penn, 1986, The occurrence of malignant tumors in immunosuppressed states, Prog Allergy, 37, 259 Hayward, 1981, Activation of a cellular one gene by promoter insertion in ALV-induced lymphoid leukosis, Nature, 290, 475, 10.1038/290475a0 Blattner, 1983, Human T-cell leukemia-lymphoma virus and adult T-cell leukemia, JAMA, 250, 1074, 10.1001/jama.250.8.1074 Seiki, 1984, Nonspecific integration of the HTLV proms genome into adult T-cell leukemia cells, Nature, 309, 640, 10.1038/309640a0 Greene, 1989, HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises, Immunol Today, 10, 272, 10.1016/0167-5699(89)90141-2 Waldmann, 1987, The arrangement of immunoglobulin and T-cell receptor genes in human lymphoproliferative disorders, Adv Immunol, 40, 247, 10.1016/S0065-2776(08)60241-2 De Wolf-Peeters, 1993, Anatomy and histophysiology of lymphoid tissue, Semin Oncol, 20, 555 MacLennan, 1994, Germinal centers, Annu Rev Immunol, 12, 117, 10.1146/annurev.iy.12.040194.001001 Banchereau, 1994, The CD40 antigen and its ligand, Annu Rev Immunol, 12, 881, 10.1146/annurev.iy.12.040194.004313 Freedman, 1993, Expression and function of adhesion receptors on normal B cells and B cell non-Hodgkin's lymphomas, Semin Hematol, 30, 318 Lakes, 1974, Immunologic characterization of human malignant lymphomas, Cancer, 34, 1488, 10.1002/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO;2-C Godfrey, 1993, Control points in early T-cell development, Immunol Today, 14, 547, 10.1016/0167-5699(93)90186-O The Non-Hodgkin's Lymphoma Pathologic Classification Project, 1982, NCI sponsored study of classification of non-Hodgkin's lymphoma: summary and description of a working formulation for clinical usage, Cancer, 49, 2112, 10.1002/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2 Lennert, 1975, The histopathology of malignant lymphoma, Br J Haematol, 31, 193, 10.1111/j.1365-2141.1975.tb00911.x Harris, 1994, A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group, Blood, 85, 1361, 10.1182/blood.V84.5.1361.1361 Mann, 1983, Criteria for the cytologic sub-classification of follicular lymphomas: a proposed alternative method, Hematol Oncol, 1, 187, 10.1002/hon.2900010209 Warnke, 1977, The coexistence of nodular and diffuse patterns in nodular non-Hodgkin's lymphoma, Cancer, 40, 1229, 10.1002/1097-0142(197709)40:3<1229::AID-CNCR2820400337>3.0.CO;2-F Ezdinli, 1987, Effect of the degree of nodularity on the survival of patients with nodular lymphomas, J Clin Oncol, 5, 413, 10.1200/JCO.1987.5.3.413 Yunis, 1982, Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma, N Engl J Med, 307, 1231, 10.1056/NEJM198211113072002 Tsujimoto, 1985, The t(14, 18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining, Science, 229, 1390, 10.1126/science.3929382 Ngan, 1989, Detection of chromosomal translocation t(14,18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas, Blood, 73, 1759, 10.1182/blood.V73.7.1759.1759 Korsmeyer, 1992, Bcl-2 initiates a new category of oncogenes: regulators of cell death, Blood, 80, 879, 10.1182/blood.V80.4.879.879 Yunis, 1989, Bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma, N Engl J Med, 320, 1047, 10.1056/NEJM198904203201605 Bartlett, 1994, Follicular large-cell lymphoma: Intermediate or low grade?, J Clin Oncol, 12, 1349, 10.1200/JCO.1994.12.7.1349 Anderson, 1993, Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group, J Clin Oncol, 11, 218, 10.1200/JCO.1993.11.2.218 Longo, 1993, What's the deal with follicular lymphomas?, J Clin Oncol, 11, 202, 10.1200/JCO.1993.11.2.202 Banks, 1992, Mantle cell lymphoma, Am J Surg Pathol, 16, 637, 10.1097/00000478-199207000-00001 Shivdasani, 1993, Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma, J Clin Oncol, 11, 802, 10.1200/JCO.1993.11.4.802 Leroux, 1991, Non-Hodgkin's lymphomas with t(11;14)(q13;q32): a subset of mantle zone-intermediate lymphocytic lymphoma?, Br J Haematol, 77, 346, 10.1111/j.1365-2141.1991.tb08582.x Raffeld, 1991, Bcl-1, t(11;14) and mantle cell-derived lymphomas, Blood, 78, 259, 10.1182/blood.V78.2.259.bloodjournal782259 Rosenberg, 1991, PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma, 88, 9638 Withers, 1991, Characterization of a candidate bcl-1 gene, Mol Cell Biol, 11, 4846, 10.1128/MCB.11.10.4846 Meusers, 1989, Multicenter randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis, Hematol Oncol, 7, 365, 10.1002/hon.2900070505 Isaacson, 1983, Malignant lymphoma of mucosa associated lymphoid tissue: a distinctive B cell lymphoma, Cancer, 52, 1410, 10.1002/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3 Isaacson, 1987, Malignant lymphoma of mucosa-associated lymphoid tissue, Histopathol, 11, 445, 10.1111/j.1365-2559.1987.tb02654.x Sheibani, 1988, Monocytoid B cell lymphoma: clinicopathologic study of 21 cases of a unique type of low grade lymphoma, Cancer, 62, 1531, 10.1002/1097-0142(19881015)62:8<1531::AID-CNCR2820620814>3.0.CO;2-A Traweek, 1989, Monocytoid B-cell lymphoma: its evolution and relationship to other low-grade B cell neoplasma, Blood, 73, 573, 10.1182/blood.V73.2.573.573 Nizze, 1991, Monocytoid B-cell lymphoma: morphologic variants and relationship to low grade B-cell lymphoma of the mucosa-associated lymphoid tissue, Histopathology, 18, 403, 10.1111/j.1365-2559.1991.tb00870.x Ngan, 1991, Monocytoid B cell lymphoma: a study of 36 cases, Hum Pathol, 22, 409, 10.1016/0046-8177(91)90125-9 Medeiros, 1991, Genotypic analysis of diffuse, mixed cell lymphomas: comparison with morphologic and immunophenotypic findings, Am J Clin Pathol, 95, 547, 10.1093/ajcp/95.4.547 Ramsay, 1988, T-cell-rich B-cell lymphoma, Am J Surg Pathol, 12, 433, 10.1097/00000478-198806000-00003 Simon, 1988, The non-Hodgkin lymphoma pathologic classification project, Ann Intern Med, 109, 939, 10.7326/0003-4819-109-12-939 Kwak, 1991, Clinical significance of morphologic subdivision in diffuse large cell lymphoma, Cancer, 68, 1988, 10.1002/1097-0142(19911101)68:9<1988::AID-CNCR2820680924>3.0.CO;2-A Fisher, 1993, Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma, N Engl J Med, 328, 1002, 10.1056/NEJM199304083281404 Bastard, 1994, LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients, Blood, 83, 2423, 10.1182/blood.V83.9.2423.2423 Offit, 1994, Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma, N Engl J Med, 331, 74, 10.1056/NEJM199407143310202 Lippman, 1988, The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype, Blood, 72, 436, 10.1182/blood.V72.2.436.436 Coiffier, 1990, Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen, Ann Oncol, 1, 45, 10.1093/oxfordjournals.annonc.a057673 Kwak, 1991, Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience, J. Clin Oncol, 9, 1426, 10.1200/JCO.1991.9.8.1426 Jacobson, 1988, Mediastinal large cell lymphoma: an uncommon subset of adult lymphoma curable with combined modality therapy, Cancer, 62, 1893, 10.1002/1097-0142(19881101)62:9<1893::AID-CNCR2820620904>3.0.CO;2-X Haioun, 1989, Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosis, Am J Clin Oncol, 12, 425, 10.1097/00000421-198910000-00013 Levabre-Bertrand, 1992, A study of 15 cases of primary medias final lymphoma or B-cell type, Cancer, 69, 2561, 10.1002/1097-0142(19920515)69:10<2561::AID-CNCR2820691028>3.0.CO;2-6 Todeschini, 1990, Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients, J Clin Oncol, 8, 804, 10.1200/JCO.1990.8.5.804 Lazzarino, 1993, Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features, J Clin Oncol, 11, 2306, 10.1200/JCO.1993.11.12.2306 Dalla-Favera, 1983, Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas, Science, 219, 963, 10.1126/science.6401867 Shirarnizu, 1991, Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association, Blood, 77, 1516, 10.1182/blood.V77.7.1516.1516 Yano, 1992, Histogenetic correlations between subcategories of small noncleaved cell lymphomas, Blood, 79, 1282, 10.1182/blood.V79.5.1282.1282 Mashal, 1991, Small non-cleaved cell lymphoma in adults, Am J Hematol, 38, 40, 10.1002/ajh.2830380107 Nathwani, 1981, Lymphoblastic lymphoma: a clinicopathologic study of 95 patients, Cancer, 48, 2347, 10.1002/1097-0142(19811201)48:11<2347::AID-CNCR2820481102>3.0.CO;2-X Lukes, 1975, Immunoblastic lymphadenopathy, a hyperimmune entity resembling Hodgkin's disease, N Engl J Med, 292, 1, 10.1056/NEJM197501022920101 Frizzera, 1975, Angio-immunoblastic lymphadenopathy, diagnosis, and clinical course, Am J Med, 59, 803, 10.1016/0002-9343(75)90466-0 Weiss, 1986, Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma, Am J Pathol, 122, 392 Godde-Salz, 1987, Chromosomal abnormalities in lymphogranulomatosis X (Lg X)/angioimmunoblastic lymphadenopathy (AILD), Leuk Res, 11, 181, 10.1016/0145-2126(87)90024-5 Knecht, 1989, Angioimmunoblastic lymphadenopathy: ten years' experience and state of current knowledge, Semin Hematol, 26, 208 Siegert, 1992, Treatment of AILD-like T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen, Am J Med, 117, 364 Stein, 1985, The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells, Blood, 66, 848, 10.1182/blood.V66.4.848.bloodjournal664848 Durkop, 1992, Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease, Cell, 68, 421, 10.1016/0092-8674(92)90180-K Mason, 1990, CD30 positive large cell lymphomas are associated with a chromosomal translocation involving 5q35, Br J Haematol, 74, 161, 10.1111/j.1365-2141.1990.tb02560.x Morris, 1994, Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM in non-Hodgkin's lymphoma, Science, 263, 1281, 10.1126/science.8122112 Paulli, 1995, CD30/Ki-1 positive lymphoproliferative disorders of the skin: clinicopathologic correlation and statistical analyses of 86 cases, J Clin Oncol, 13, 1343, 10.1200/JCO.1995.13.6.1343 McDonnell, 1989, bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation, Cell, 57, 79, 10.1016/0092-8674(89)90174-8 Yano, 1993, Molecular analysis of the BCL-3 locus at chromosome 17q22 in B-cell neoplasms, Blood, 82, 1813, 10.1182/blood.V82.6.1813.1813 McKeithan, 1990, Identification of a transcriptional unit adjacent to the breakpoint in the 14;19 translocation of chronic lymphocytic leukemia, Genes Chromosom Cancer, 1, 247, 10.1002/gcc.2870010310 Ye, 1993, Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma, Science, 262, 747, 10.1126/science.8235596 Miki, 1994, Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Kruppel-like zinc-finger protein, Blood, 83, 26, 10.1182/blood.V83.1.26.bloodjournal83126 Gaidano, 1994, Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype, Blood, 84, 397, 10.1182/blood.V84.2.397.397 Lo Coco, 1993, p53 mutations are associated with histologic transformation of follicular lymphoma, Blood, 82, 2289, 10.1182/blood.V82.8.2289.2289 Hsu, 1984, Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease, Am J Clin Pathol, 82, 29, 10.1093/ajcp/82.1.29 Leoncini, 1990, Hodgkin's disease and CD30-positive ariaplastic large cell lymphomas — a continuous spectrum of malignant disorders, Am J Pathol, 137, 1047 Kaplan, 1990, Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma, J Clin Oncol, 8, 1966, 10.1200/JCO.1990.8.12.1966 Front, 1990, Ga-67 SPECT before and after treatment of lymphoma, Radiol, 175, 515, 10.1148/radiology.175.2.2183289 Hill, 1993, Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma, J Clin Oncol, 11, 2273, 10.1200/JCO.1993.11.11.2273 Negendank, 1990, Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlations, Radiol, 177, 209, 10.1148/radiology.177.1.2399318 Carbone, 1971, Report of the committee on Hodgkin's disease staging, Cancer Res, 31, 1860 Shipp, 1986, Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or MBACOD, Ann Intern Med, 104, 757, 10.7326/0003-4819-104-6-757 Danieu, 1986, Predictive model for prognosis in advanced diffuse histiocytic lymphoma, Cancer Res, 46, 5372 Velasquez, 1989, Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival data, Blood, 74, 551, 10.1182/blood.V74.2.551.551 Hoskins, 1991, Prognostic variables in patients with diffuse large-cell lymphoma treated with MACOP-B, J Clin Oncol, 9, 220, 10.1200/JCO.1991.9.2.220 Coiffier, 1991, Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy, J Clin Oncol, 9, 211, 10.1200/JCO.1991.9.2.211 Shipp, 1993, A predictive model for aggressive NHL: the International Non-Hodgkin's Lymphoma Prognostic Factors Project, N Engl J Med, 329, 987, 10.1056/NEJM199309303291402 Swan, 1989, A new serologic staging system for large cell lymphomas based on initial beta2-microglobulin and lactate dehydrogenase levels, J Clin Oncol, 7, 1518, 10.1200/JCO.1989.7.10.1518 Berinstein, 1993, Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma, J Clin Oncol, 11, 1344, 10.1200/JCO.1993.11.7.1344 Finke, 1993, Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localizedstage follicular lymphoma, J Clin Oncol, 11, 1668, 10.1200/JCO.1993.11.9.1668 Bush, 1977, Radiation therapy of localized non-Hodgkin's lymphoma, Cancer Treat Rep, 61, 1129 Paryani, 1983, Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II, Cancer, 52, 2300, 10.1002/1097-0142(19831215)52:12<2300::AID-CNCR2820521224>3.0.CO;2-Y McLaughlin, 1986, Stage I-II follicular lymphoma: treatment results for 76 patients, Cancer, 58, 1596, 10.1002/1097-0142(19861015)58:8<1596::AID-CNCR2820580803>3.0.CO;2-G Lawrence, 1988, Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute, Int J Radiat Oncol Biol Phys, 14, 417, 10.1016/0360-3016(88)90254-4 Landberg, 1979, CVP-remission-maintenance in stage I or II non-Hodgkin's lymphomas, Cancer, 44, 831, 10.1002/1097-0142(197909)44:3<831::AID-CNCR2820440307>3.0.CO;2-S Manfardini, 1980, Improved five-year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma, Int J Radiat Oncol Biol Phys, 6, 125, 10.1016/0360-3016(80)90027-9 Nissen, 1983, A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas, Cancer, 52, 1, 10.1002/1097-0142(19830701)52:1<1::AID-CNCR2820520102>3.0.CO;2-M Yahalom, 1993, Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I lowgrade and intermediate-grade non-Hodgkin's lymphoma, Cancer, 71, 2342, 10.1002/1097-0142(19930401)71:7<2342::AID-CNCR2820710728>3.0.CO;2-I Dana, 1993, Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy, J Clin Oncol, 11, 644, 10.1200/JCO.1993.11.4.644 Horning, 1984, The natural history of initially untreated lowgrade non-Hodgkin's lymphoma, N Engl J Med, 311, 1471, 10.1056/NEJM198412063112303 Young, 1988, The treatment of indolent lymphomas: watchful waiting vs aggressive combined modality treatment, Semin Hematol, 25, 11 McLäughlin, 1994, Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement, Ann Oncol, 5, 73, 10.1093/annonc/5.suppl_2.S73 Longo, 1984, Prolonged initial remission in patients with nodular mixed lymphoma, Ann Intern Med, 100, 651, 10.7326/0003-4819-100-5-651 Glick, 1981, Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy, Blood, 58, 920, 10.1182/blood.V58.5.920.920 Paryani, 1984, The role of radiation therapy in the management of stage III follicular lymphomas, J Clin Oncol, 2, 841, 10.1200/JCO.1984.2.7.841 Jacobs, 1993, Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results, J Clin Oncol, 11, 233, 10.1200/JCO.1993.11.2.233 McLaughlin, 1987, Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen, J Clin Oncol, 5, 867, 10.1200/JCO.1987.5.6.867 Lister, 1978, Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type, Br Med J, 1, 533, 10.1136/bmj.1.6112.533 Hoppe, 1981, The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation, Blood, 58, 592, 10.1182/blood.V58.3.592.592 Ezdinli, 1985, Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma, J Clin Oncol, 3, 769, 10.1200/JCO.1985.3.6.769 Hochster, 1992, Activity of fiudarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study, J Clin Oncol, 10, 28, 10.1200/JCO.1992.10.1.28 Redman, 1992, Phase II trial of fiudarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma, J Clin Oncol, 10, 790, 10.1200/JCO.1992.10.5.790 Kay, 1992, 2-chlorodeoxyadenosine treatment of low-grade lymphomas, J Clin Oncol, 10, 371, 10.1200/JCO.1992.10.3.371 Hoffman, 1994, 2-chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma, J Clin Oncol, 12, 788, 10.1200/JCO.1994.12.4.788 Cheson, 1992, New antimetabolites in the treatment of human malignancies, Semin Oncol, 19, 695 Byrd, 1994, Fludarabine therapy for lymphoid malignancies is associated with hemolytic anemia [Abstract], 13, 991A Freedman, 1991, Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma, Blood, 77, 2524, 10.1182/blood.V77.11.2524.2524 Gribben, 1993, Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma, Blood, 81, 3449, 10.1182/blood.V81.12.3449.3449 Kessinger, 1994, Peripheral blood stem cell transplantation in malignant lymphomas, Hematol Oncol Ann, 2, 47 Levitt, 1987, Alpha-2b IFN in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma, Semin Oncol, 14, 18 Wagstaff, 1987, A phase II study of human recombinant alpha 2 interferon in patients with low grade non-Hodgkin's lymphoma, Br J Cancer, 55, 225, 10.1038/bjc.1987.42 Wagsaff, 1987, A phase II study of human recombinant alpha 2 interferon in patients with low grade non-Hodgkin's lymphoma, Br J Cancer, 55, 225, 10.1038/bjc.1987.42 Price, 1991, IFN-alpha 2b in the treatment of follicular lymphoma: preliminary results of a trial in progress, Ann Oncol, 2, 141, 10.1093/annonc/2.suppl_2.141 Andersen, 1993, Interferon alfa plus chemotherapy for non-Hodgkin's lymphoma: five-year follow-up, N Engl J Med, 329, 1821, 10.1056/NEJM199312093292419 Solal-Celigny, 1993, Recombinant interferon alpha-2b combined with a regimen containing doxorubicin inpatients with advanced follicular lymphoma, N Engl J Med, 329, 1608, 10.1056/NEJM199311253292203 Levy, 1991, Antibodies in cancer therapy: B-cell lymphomas, 512 Vokes, 1985, Long-term survival of patients with localized diffuse histiocytic lymphoma, J Clin Oncol, 3, 1309, 10.1200/JCO.1985.3.10.1309 Hallahan, 1989, The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone, Int J Radiat Oncol Biol Phys, 17, 767, 10.1016/0360-3016(89)90064-3 Jones, 1989, Long-term follow-up analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy, J Clin Oncol, 7, 1186, 10.1200/JCO.1989.7.9.1186 Tondini, 1993, Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas, J Clin Oncol, 11, 720, 10.1200/JCO.1993.11.4.720 Cooper, 1994, Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma, J Clin Oncol, 12, 769, 10.1200/JCO.1994.12.4.769 Gordon, 1992, Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma, N Engl J Med, 327, 1342, 10.1056/NEJM199211053271903 Shipp, 1990, The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen, J Clin Oncol, 8, 84, 10.1200/JCO.1990.8.1.84 Sertoli, 1994, MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group, J Clin Oncol, 12, 1366, 10.1200/JCO.1994.12.7.1366 Longo, 1991, Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial, J Clin Oncol, 9, 25, 10.1200/JCO.1991.9.1.25 Fisher, 1977, Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy, Am J Med, 63, 177, 10.1016/0002-9343(77)90230-3 Meyer, 1993, Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphoma, N Engl J Med, 329, 1770, 10.1056/NEJM199312093292404 Gianni, 1994, 5-year update of the Milan Cancer Institute randomized trial of high-dose sequential vs MACOP-B therapy for diffuse large-cell lymphomas [Abstract], 13, 1263A Maloney DG, Bodkin D, Grillo-Lopez AJ, et al. IDEC-C2B8: final report on a phase II trial in relapsed non-Hodgkin's lymphoma. Blood 84(suppl 1):661A. Kaminski, 1993, Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody, N Engl J Med, 329, 459, 10.1056/NEJM199308123290703 Press, 1993, Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support, N Engl J Med, 329, 1219, 10.1056/NEJM199310213291702 Grossbard, 1993, Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms, J Clin Oncol, 11, 726, 10.1200/JCO.1993.11.4.726 Shipp, 1989, Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy, J Clin Oncol, 7, 613, 10.1200/JCO.1989.7.5.613 Weeks, 1991, Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission, J Clin Oncol, 9, 1196, 10.1200/JCO.1991.9.7.1196 Surbone, 1988, Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management, J Clin Oncol, 6, 1832, 10.1200/JCO.1988.6.12.1832 Letzer, 1993, How to treat the patient with relapsed NHL, Contemp Oncol, 4, 18 Rossof, 1979, Phase II evaluation if cisdichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study, Cancer Treat Rep, 63, 1605 Cavalli, 1981, Phase II trial of cis-dichlorodiammineplatinum (II) in advanced malignant lymphoma: a study of the Cancer and Acute Leukemia Group B, Cancer, 48, 1927, 10.1002/1097-0142(19811101)48:9<1927::AID-CNCR2820480902>3.0.CO;2-# Danieu, 1986, Limited activity of carboplatin in malignant lymphoma, Cancer Treat Rep, 70, 931 Younes, 1995, Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma, J Clin Oncol, 13, 583, 10.1200/JCO.1995.13.3.583 Wilson, 1995, Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas, J Clin Oncol, 13, 381, 10.1200/JCO.1995.13.2.381 Ohno, 1990, An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma, J Clin Oncol, 8, 1907, 10.1200/JCO.1990.8.11.1907 Velasquez, 1988, Effective salvage therapy for lymphoma with cisplatin in combination with high-dose ara-C and dexamethasone (DHAP), Blood, 71, 117, 10.1182/blood.V71.1.117.117 Press, 1991, Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation, J Clin Oncol, 9, 423, 10.1200/JCO.1991.9.3.423 Chauvin, 1991, Parma International Protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation, Blood, 77, 1587, 10.1182/blood.V77.7.1587.1587 Velasquez, 1994, ESHAP-an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study, J Clin Oncol, 12, 1169, 10.1200/JCO.1994.12.6.1169 Cabanillas, 1990, Ifosfamide combinations in lymphoma, Semin Oncol, 17, 58 Cross, 1991, Dexamethasone/ifosfamide/cisplatin/etoposide (DICE) as therapy for patients with advanced refractory non-Hodgkin's lymphoma: preliminary report of a phase II study, Ann Oncol, 2, 43, 10.1093/annonc/2.suppl_1.43 Rodriguez MA, Cabanillas FC, Velasquez W, et al. Results of a salvage treatment program for relapsing lymphoma: mesna/ifosfamide, novantrone, and etoposide (MINE), consolidated with etoposide, solumedrol, high dose arabinoside and cisplatinum (ESHAP). J Clin Oncol (In press.) Chao, 1990, CEPP(B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma, Blood, 76, 1293, 10.1182/blood.V76.7.1293.1293 Wilson, 1993, EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma, J Clin Oncol, 11, 1573, 10.1200/JCO.1993.11.8.1573 Miller, 1991, P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamfi, J Clin Oncol, 9, 17, 10.1200/JCO.1991.9.1.17 Appelbaum, 1987, Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation, J Clin Oncol, 5, 1340, 10.1200/JCO.1987.5.9.1340 Phillips, 1984, Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow, N Engl J Med, 310, 1557, 10.1056/NEJM198406143102403 Philip, 1987, High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma, N Engl J Med, 316, 1493, 10.1056/NEJM198706113162401 Takvorian, 1987, Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis, N Engl J Med, 316, 1499, 10.1056/NEJM198706113162402 Freedman, 1990, Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse, J Clin Oncol, 8, 784, 10.1200/JCO.1990.8.5.784 Chopra, 1992, Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group registry data, J Clin Oncol, 10, 1690, 10.1200/JCO.1992.10.11.1690 Phillips, 1990, The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation, Blood, 75, 831, 10.1182/blood.V75.4.831.831 Mills, 1995, BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma, J Clin Oncol, 13, 588, 10.1200/JCO.1995.13.3.588 Lazarus, 1992, High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma, J Clin Oncol, 10, 1682, 10.1200/JCO.1992.10.11.1682 Vose, 1993, High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma, J Clin Oncol, 11, 1846, 10.1200/JCO.1993.11.10.1846 Goldstone, 1992, High-dose therapy for the treatment of non-Hodgkin's lymphoma, 662 Bierman, 1994, Autologous bone marrow transplantations for non-Hodgkin's lymphoma, 683 Philip, 1991, PARMA international protocol: pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients), Ann Oncol, 2, 57, 10.1093/annonc/2.suppl_1.57 Philip, 1995, Autologous bone marrow transplantation vs DHAP in relapsed NHL: final analysis of the PARMA randomized study [Abstract], 14, 1220A Gulati, 1988, Autologous bone marrow transplantation for patients with poor-prognosis lymphoma, J Clin Oncol, 6, 1303, 10.1200/JCO.1988.6.8.1303 Nademanee, 1992, High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study, Blood, 80, 1130, 10.1182/blood.V80.5.1130.1130 Hag, 1994, Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review, J Clin Oncol, 12, 1074, 10.1200/JCO.1994.12.5.1074 Verdonck, 1995, Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma, N Engl J Med, 332, 1045, 10.1056/NEJM199504203321601 Haioun, 1993, Comparison of ABMT with sequential chemotherapy for aggressive NHL in first complete remission: a study on 464 patients (LNH 87 protocol), Blood, 82, 334A Coiffier, 1994, 12, 226 Grossbard, 1992, Monoclonal antibody-based therapies of leukemia and lymphoma, Blood, 80, 863, 10.1182/blood.V80.4.863.863 Dillman, 1994, Antibodies as cytotoxic therapy, J Clin Oncol, 12, 1497, 10.1200/JCO.1994.12.7.1497 Meeker, 1985, A clinical trial of anti-idiotype therapy for B cell malignancy, Blood, 65, 1349, 10.1182/blood.V65.6.1349.bloodjournal6561349 Hu, 1989, Phase I clinical trial of LYM-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies, Hematol Oncol, 7, 155, 10.1002/hon.2900070207 Hale, 1988, Remission induction in non-Hodgkin's lymphoma with reshapod human monoclonal antibody CAMPATH-1H, Lancet, 2, 1394, 10.1016/S0140-6736(88)90588-0 Hekman, 1991, Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody, Cancer Immunol Immunother, 32, 364, 10.1007/BF01741331 Press, 1987, Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas, Blood, 69, 584, 10.1182/blood.V69.2.584.584 Dillman, 1984, Therapy of CLL and cutaneous T-cell lymphoma with T101 monoclonal antibody, J Clin Oncol, 2, 881, 10.1200/JCO.1984.2.8.881 Foon, 1984, Effects of monoclonal antibody therapy in patients with CLL, Blood, 64, 1085, 10.1182/blood.V64.5.1085.1085 Miller, 1983, Monoclonal antibody therapeutic trials in seven patients with T cell lymphoma, Blood, 62, 988, 10.1182/blood.V62.5.988.988 Pal, 1994, Immunotoxins and recombinant toxins for cancer treatment, 3 Hertier, 1988, A phase I study of T101-ricin A-chain immunotoxin in refractory CLL, J Biol Resp Modif, 7, 97 LeMaistre, 1991, Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma, Blood, 78, 1173, 10.1182/blood.V78.5.1173.1173 Vitetta, 1991, Phase I immunotoxin trial in patients with B-cell lymphoma, Cancer Res, 51, 4052 Dalton, 1993, Overcoming the multidrug-resistant phenotype, 2655 Yahanda, 1992, Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance, J Clin Oncol, 10, 1624, 10.1200/JCO.1992.10.10.1624 Wilson WH, Janis-Dow C, Bryant G, et al. Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy. J Clin Oncol (In press.) Zeigler, 1974, Burkitt's lymphomas, Pathobiology Annu, 4, 129 Bernstein, 1986, Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types), J Clin Oncol, 4, 847, 10.1200/JCO.1986.4.6.847 Straus, 1991, Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia, Am J Med, 90, 328, 10.1016/0002-9343(91)80013-C Lopez, 1990, Small noncleaved cell lymphoma in adults: superior results for stages I–III disease, J Clin Oncol, 8, 615, 10.1200/JCO.1990.8.4.615 McMaster, 1991, Effective treatment of small-noncleaved cell lymphoma with high-intensity, brief-duration chemotherapy, J Clin Oncol, 9, 941, 10.1200/JCO.1991.9.6.941 Philip, 1988, High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma, J Clin Oncol, 6, 1118, 10.1200/JCO.1988.6.7.1118 Longo, 1994, Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy, J Clin Oncol, 12, 2153, 10.1200/JCO.1994.12.10.2153 Rivera, 1993, Treatment of acute lymphoblastic leukemia: 30 years' experience at St. Jude Children's Research Hospital, N Engl J Med, 329, 1289, 10.1056/NEJM199310283291801 Slater, 1986, Lymphoblastic lymphoma in adults, J Clin Oncol, 4, 57, 10.1200/JCO.1986.4.1.57 Coleman, 1986, Treatment of lymphoblastic lymphoma in adults, J Clin Oncol, 4, 1628, 10.1200/JCO.1986.4.11.1628 Sweetenham, 1994, High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation, J Clin Oncol, 12, 1358, 10.1200/JCO.1994.12.7.1358 Gospodarowicz, 1987, Patterns of disease in localized extranodal lymphomas, J Clin Oncol, 5, 875, 10.1200/JCO.1987.5.6.875 Pan, 1989, The bcl-2 gene in primary B-cell lymphomas of MALT, Am J Pathal, 135, 7 Jacobs, 1985, NHL of head and neck extranodal sites, Int J Radiat Oncol Biol Phys, 11, 357, 10.1016/0360-3016(85)90158-0 Banfi, 1972, Malignant lymphomas of Waldeyer's ring, Br Med J, 3, 140, 10.1136/bmj.3.5819.140 Doll, 1986, Malignant lymphoma of the testis, Am J Med, 81, 515, 10.1016/0002-9343(86)90308-6 Genta, 1993, Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy, Hum Pathol, 24, 577, 10.1016/0046-8177(93)90235-9 Doglioni, 1992, High incidence of gastric lymphoma in northeastern Italy, Lancet, 339, 834, 10.1016/0140-6736(92)90280-G Wotherspoon, 1991, Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma, Lancet, 338, 1175, 10.1016/0140-6736(91)92035-Z Parsonnet, 1994, Helicobacter pylori infection and gastric lymphoma, N Engl J Med, 330, 1267, 10.1056/NEJM199405053301803 Hussell, 1993, The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori, Lancet, 342, 571, 10.1016/0140-6736(93)91408-E Wotherspoon, 1993, Regression of primary lowgrade B-cell gastric lymphomas of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori, Lancet, 342, 575, 10.1016/0140-6736(93)91409-F Chan, 1990, Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach, Am J Pathol, 136, 1153 Salles, 1991, Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen: a study of the Groupe d'Etude des Lymphomes Agressifs, Am J Med, 90, 77, 10.1016/0002-9343(91)90509-V Shimm, 1983, Primary gastric lymphoma, Cancer, 52, 2044, 10.1002/1097-0142(19831201)52:11<2044::AID-CNCR2820521113>3.0.CO;2-5 Valicenti, 1993, Analysis of prognostic factors in localized gastric lymphoma: the importance of bulk of disease, Int J Radiat Oncol Biol Phys, 27, 591, 10.1016/0360-3016(93)90384-8 Paulson, 1983, Large cell lymphomas of the stomach: improved prognosis with complete resection of all intrinsic gastrointestinal disease, J Clin Oncol, 1, 263, 10.1200/JCO.1983.1.4.263 Thirlby, 1993, GI lymphoma: a surgical perspective, Oncology, 7, 29 Shiu, 1986, Recent results of multimodal therapy of gastric lymphoma, Cancer, 58, 1389, 10.1002/1097-0142(19861001)58:7<1389::AID-CNCR2820580702>3.0.CO;2-Y Maor, 1990, Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma, J Clin Oncol, 8, 266, 10.1200/JCO.1990.8.2.266 Burgers, 1988, Treatment results of primary stage I and II NHL of the stomach, Radiother Oncol, 11, 319, 10.1016/0167-8140(88)90203-4 Eby, 1988, Increasing incidence of primary brain lymphoma in the US, Cancer, 62, 2461, 10.1002/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO;2-M Fine, 1993, Primary central nervous system lymphoma, Ann Intern Med, 119, 1093, 10.7326/0003-4819-119-11-199312010-00007 Bashir, 1989, Detection of Epstein-Barr virus in CNS lymphomas by in-situ hybridization, Neurology, 39, 813, 10.1212/WNL.39.6.813 Bignon, 1991, Detection of Epstein-Barr virus sequences in primary brain lymphoma without immunodeficiency, Neurology, 41, 1152, 10.1212/WNL.41.7.1152 DeAngelis, 1995, Current management of primary central nervous system lymphoma, Oncology, 9, 63 Michalski, 1990, Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure, Radiology, 176, 855, 10.1148/radiology.176.3.2389047 Loeffier, 1985, Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival, J Clin Oncol, 3, 490, 10.1200/JCO.1985.3.4.490 Nelson, 1992, Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315, Int J Radiat Oncol, 23, 9, 10.1016/0360-3016(92)90538-S Neuwelt, 1991, Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function, J Clin Oncol, 9, 1580, 10.1200/JCO.1991.9.9.1580 DeAngelis, 1992, Combined modality therapy for primary CNS lymphoma, J Clin Oncol, 10, 635, 10.1200/JCO.1992.10.4.635 Glass, 1994, Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome, J Neurosurg, 81, 188, 10.3171/jns.1994.81.2.0188 McLaughlin, 1988, Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma, J Natl Cancer Inst, 80, 1408, 10.1093/jnci/80.17.1408 Kuzel, 1991, Mycosis fungoides and the Sezary syndrome: a review of pathogenesis, diagnosis, and therapy, J Clin Oncol, 9, 1298, 10.1200/JCO.1991.9.7.1298 Bunn, 1979, Report of the Committee on Staging and Classification of Cutaneous T-Cell lymphomas, Cancer Treat Rep, 63, 725 Sausville, 1988, Histopathologic staging at initial diagnosis of mycosis fungoides and the Sezary syndrome: definition of three distinctive prognostic groups, Ann Intern Med, 109, 372, 10.7326/0003-4819-109-5-372 Nasu, 1985, Immunopathology of cutaneous T-cell lymphomas, Am J Pathol, 119, 436 Rosen, 1986, Evaluation of computed tomography in the staging of cutaneous T-cell lymphomas, Arch Dermatol, 122, 884, 10.1001/archderm.122.8.884 Salhany, 1989, Marrow involvement in cutaneous T-cell lymphoma: a clinicopathologic study of 60 cases, Am J Clin Pathol, 92, 747, 10.1093/ajcp/92.6.747 Gilchrest, 1979, Methoxsalen photochemotherapy for mycosis fungoides, Cancer Treat Rep, 63, 663 Hoppe, 1979, Electron-beam therapy for mycosis fungoides: the Stanford University experience, Cancer Treat Rep, 63, 691 Vonderheid, 1979, A 10-year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron-beam radiation therapy, Cancer Treat Rep, 63, 681 Edelson, 1987, Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: preliminary results, N Engl J Med, 316, 297, 10.1056/NEJM198702053160603 Kaye, 1989, A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides, N Engl J Med, 321, 1784, 10.1056/NEJM198912283212603 Bunn, 1986, The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas, Cancer, 57, 1689, 10.1002/1097-0142(19860415)57:8+<1689::AID-CNCR2820571311>3.0.CO;2-M Kuzel, 1990, Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma, J Natl Cancer Inst, 82, 203, 10.1093/jnci/82.3.203 Kessler, 1983, Treatment of cutaneous T-cell lymphoma with 13-cis-retinoic acid, Lancet, 1, 1345, 10.1016/S0140-6736(83)92136-0 Von Hoff, 1990, Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: a Southwest Oncology Group study, J Natl Cancer Inst, 82, 1353, 10.1093/jnci/82.16.1353 O'Brien, 1994, 2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders, Blood, 84, 733, 10.1182/blood.V84.3.733.733 Vose, 1988, The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma, J Clin Oncol, 6, 1838, 10.1200/JCO.1988.6.12.1838 Dixon, 1986, Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience, J Clin Oncol, 4, 295, 10.1200/JCO.1986.4.3.295 O'Connell, 1986, Initial chemotherapy doses for elderly patients with malignant lymphoma, J Clin Oncol, 4, 1418 O'Reilly, 1993, In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy, J Clin Oncol, 11, 2250, 10.1200/JCO.1993.11.11.2250 Tirelli, 1992, A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma, J Clin Oncol, 10, 228, 10.1200/JCO.1992.10.2.228 Penn, 1987, Cancers following cyclosporine therapy, Transplantation, 43, 32, 10.1097/00007890-198701000-00008 Nalesnik, 1988, The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporin Aprednisone immunosuppression, Am J Pathol, 133, 177 Hanto, 1985, Epstein-Barr virus immunodeficiency and B cell lymphoproliferation, Transplantation, 39, 461, 10.1097/00007890-198505000-00001 Hemdier, 1994, Pathogenesis of AIDS lymphomas, AIDS, 8, 1025, 10.1097/00002030-199408000-00003 Levine, 1992, Acquired immunodeficiency syndrome-related lymphoma, Blood, 80, 8, 10.1182/blood.V80.1.8.8 Monfardini, 1994, Treatment of AIDS-related cancer, Cancer Treat Rev, 20, 149, 10.1016/0305-7372(94)90025-6 Pluda, 1990, Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy, Ann Intern Med, 113, 276, 10.7326/0003-4819-113-4-276 Moore, 1991, Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine, JAMA, 265, 2208, 10.1001/jama.265.17.2208 Levine, 1991, Low dose chemotherapy with CNS prophylaxis and zidovudine maintenance in AIDS-related lymphoma, JAMA, 266, 84, 10.1001/jama.266.1.84 Kaplan, 1995, Randomized trial of standard dose mBACOD with GM-CSF vs reduced dose mBACOD for systemic HIV-associated lymphoma [Abstract], 14, 818A Sparano, 1993, Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus and human T-cell leukemia versus Type I-related non-Hodgkin's lymphoma: a highly active regimen, Blood, 81, 2810, 10.1182/blood.V81.10.2810.2810